SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-060363
Filing Date
2022-05-13
Accepted
2022-05-13 16:22:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2215580d1_defa14a.htm DEFA14A 15142
2 GRAPHIC logo.jpg GRAPHIC 5401
  Complete submission text file 0001104659-22-060363.txt   23770
Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35668 | Film No.: 22923073
SIC: 2834 Pharmaceutical Preparations